Integrated BioPharma, Inc. (INBP)
0.167
-0.01
(-7.22%)
USD |
OTCM |
Aug 24, 16:00
Integrated BioPharma Total Assets (Quarterly) : 26.67M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 26.67M |
| December 31, 2025 | 23.55M |
| September 30, 2025 | 25.54M |
| June 30, 2025 | 24.90M |
| March 31, 2025 | 25.66M |
| December 31, 2024 | 25.66M |
| September 30, 2024 | 26.18M |
| June 30, 2024 | 26.21M |
| March 31, 2024 | 26.94M |
| December 31, 2023 | 25.72M |
| September 30, 2023 | 26.64M |
| June 30, 2023 | 25.43M |
| March 31, 2023 | 26.88M |
| December 31, 2022 | 26.05M |
| September 30, 2022 | 26.36M |
| June 30, 2022 | 25.25M |
| March 31, 2022 | 27.70M |
| December 31, 2021 | 27.07M |
| September 30, 2021 | 24.34M |
| June 30, 2021 | 25.44M |
| March 31, 2021 | 26.13M |
| December 31, 2020 | 25.26M |
| September 30, 2020 | 24.63M |
| June 30, 2020 | 22.94M |
| March 31, 2020 | 20.64M |
| Date | Value |
|---|---|
| December 31, 2019 | 19.97M |
| September 30, 2019 | 19.64M |
| June 30, 2019 | 19.79M |
| March 31, 2019 | 22.22M |
| December 31, 2018 | 22.58M |
| September 30, 2018 | 19.72M |
| June 30, 2018 | 14.57M |
| March 31, 2018 | 14.62M |
| December 31, 2017 | 15.65M |
| September 30, 2017 | 13.38M |
| June 30, 2017 | 15.20M |
| March 31, 2017 | 13.61M |
| December 31, 2016 | 15.00M |
| September 30, 2016 | 14.65M |
| June 30, 2016 | 14.08M |
| March 31, 2016 | 14.11M |
| December 31, 2015 | 14.22M |
| September 30, 2015 | 12.08M |
| June 30, 2015 | 11.62M |
| March 31, 2015 | 12.42M |
| December 31, 2014 | 13.66M |
| September 30, 2014 | 13.14M |
| June 30, 2014 | 11.58M |
| March 31, 2014 | 10.32M |
| December 31, 2013 | 11.77M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Medifast, Inc. | 260.40M |
| BioForce Nanosciences Holdings, Inc. | 2.388M |
| Skinvisible, Inc. | 0.1233M |
| Nevis Brands, Inc. | 1.230M |
| Skinhealth Systems, Inc. | 486.57M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.687M |
| Shareholders Equity (Quarterly) | 18.98M |
| Debt to Equity Ratio | 0.1763 |
| Current Ratio | 3.252 |
| Net Debt Paydown Yield | -4.81% |